Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment

Last updated: February 24, 2025
Sponsor: Centre Antoine Lacassagne
Overall Status: Active - Recruiting

Phase

N/A

Condition

Cancer

Treatment

blood sampling

Clinical Study ID

NCT06851975
2018-61
  • Ages > 18
  • All Genders

Study Summary

Research into biomarkers predictive of survival and response to cancer treatment

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient having a blood test, venous line insertion or injection on an implantablevenous device scheduled as part of their standard care,

  • Patient who has read the information note and stated that he/she has no objections

  • Patient who has not objected to the use of this data for medical research purposes

  • Patient with social security cover.

Exclusion

Exclusion Criteria:

  • Patient already included in the study

  • Patient considered to be a vulnerable person; vulnerable persons are defined inarticle L1121-5 to -8

Study Design

Total Participants: 40000
Treatment Group(s): 1
Primary Treatment: blood sampling
Phase:
Study Start date:
January 07, 2020
Estimated Completion Date:
December 31, 2099

Connect with a study center

  • Centre Antoine Lacassagne

    Nice, 0600
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.